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XPC-hHR23B protein complex is speciﬁcally involved in nucleotide excision repair (NER) of DNA lesions on
transcriptionally inactive sequences as well as the nontranscribed strand of active genes. Here we demonstrate
that not only highly puriﬁed recombinant hHR23B (rhHR23B) but also a second human homolog of the
Saccharomyces cerevisiae Rad23 repair protein, hHR23A, stimulates the in vitro repair activity of recombinant
human XPC (rhXPC), revealing functional redundancy between these human Rad23 homologs. Coprecipita-
tion experiments with His-tagged rhHR23 as well as sedimentation velocity analysis showed that both rhHR23
proteins in vitro reconstitute a physical complex with rhXPC. Both complexes were more active than free
rhXPC, indicating that complex assembly is required for the stimulation. rhHR23B was shown to stimulate an
early stage of NER at or prior to incision. Furthermore, both rhHR23 proteins function in a deﬁned NER
system reconstituted with puriﬁed proteins, indicating direct involvement of hHR23 proteins in the DNA repair
reaction via interaction with XPC.
Nucleotide excision repair (NER) is the main pathway for
cells to remove DNA lesions caused by UV irradiation as well
as various chemical mutagens (6). The molecular mechanism
of NER has been extensively investigated in Escherichia coli (8,
12, 17, 32). Based on studies with this prokaryotic system, the
NER reaction could be dissected into several steps: (i) recog-
nition of DNA damage, probably accompanied by chromatin
remodelling; (ii) introduction of asymmetric single-strand
breaks on both sides of the injury; (iii) removal of the short
oligonucleotide containing the lesion; (iv) gap-ﬁlling DNA syn-
thesis by DNA polymerases; and (v) resealing of the resulting
nicks by DNA ligase. Although some general features of the
eukaryotic NER mechanism are similar to the prokaryotic sys-
tem, there are many important differences. Only six E. coli
proteins (i.e., UvrA, UvrB, UvrC, UvrD, DNA polymerase I,
and DNA ligase) are required to accomplish the core of the
NER reaction in vitro. The eukaryotic NER system, however,
appears to be much more complex, involving at least 20 factors
(13, 35).
Impaired NER activity has been found to be associated with
several rare autosomal recessive human disorders, including
xeroderma pigmentosum (XP), Cockayne syndrome (CS), and
trichothiodystrophy (TTD) (2). So far, seven XP (XP-A to -G),
two CS (CS-A and -B), and three TTD (TTD-A, XP-B, and
XP-D) NER-deﬁcient complementation groups have been
identiﬁed by cell fusion. Many mammalian NER genes have
been cloned by using either mutant ﬁbroblasts from patients or
NER-deﬁcient, UV-sensitive Chinese hamster ovary cells (3).
For some of these genes, a possible role in the NER reaction
has been suggested on the basis of their amino acid sequences
as well as biochemical properties of the isolated gene products.
On the other hand, additional factors involved in the mamma-
lian NER have been identiﬁed from extensive analyses of cell-
free NER systems, and some models for the eukaryotic NER
mechanism have been proposed (see reviews in references 24
and 35). Several laboratories have recently succeeded in re-
constituting the core of eukaryotic NER reactions with puriﬁed
proteins (1, 10, 22).
XPC protein is involved in NER of DNA lesions on tran-
scriptionally inactive sequences as well as the nontranscribed
strand of active genes (33, 34) and is required for in vitro NER
of many types of DNA lesions (20, 25). However, certain kinds
of lesions could be repaired without XPC in vitro (21) and the
precise role of XPC in the global genome repair NER sub-
pathway remains to be elucidated. Human XPC protein was
found to be tightly complexed in vivo with hHR23B (human
homolog of Rad23), which shows overall homology to the
Saccharomyces cerevisiae NER factor, Rad23 (20). Unlike yeast
cells, a second Rad23 homolog, designated HR23A, has been
identiﬁed in human (20) as well as murine (31) cells. The
RAD23 gene has thus been duplicated during eukaryotic evo-
lution. Indirect immunoﬂuorescence studies revealed that
XPC and both hHR23 proteins are predominantly localized in
the nucleus (30). Although XPC protein is bound to hHR23B
in a quantitative manner, hHR23B is much more abundant
than XPC so that a majority of hHR23B is present in a free
form in vivo (28, 30). Both the RAD23 gene duplication and
the presence of two forms of hHR23B suggest that the protein
may have multiple functions. Despite the overall sequence
homology of the two human Rad23 homologs, almost all XPC
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6924molecules appear to be complexed in vivo with hHR23B, not
with hHR23A.
Using a reconstituted in vitro NER system devoid of endog-
enous XPC and hHR23B, we have previously shown that re-
combinant hHR23B protein (rhHR23B) signiﬁcantly stimu-
lates the activity of recombinant hXPC protein (rhXPC) (28).
In the accompanying paper, we identiﬁed a domain in hHR23B
that is responsible for XPC binding as well as its stimulatory
activity (19). Because the amino acid sequence of this domain
is well conserved between the two human Rad23 homologs, the
XPC-binding and -stimulating activities of hHR23A have been
of interest. Here we document and characterize the XPC-
stimulating activity of both hHR23 proteins expressed in
E. coli.
MATERIALS AND METHODS
Puriﬁcation of repair proteins. rhXPC protein was expressed in an insect cell
line, Sf9, by a baculovirus expression system and puriﬁed as described previously
(28). Nontagged and His-tagged versions of rhHR23A and rhHR23B proteins
were expressed in E. coli and puriﬁed as described in the accompanying paper
(19). Recombinant human proliferating cell nuclear antigen (PCNA) was puri-
ﬁed from E. coli BL21(DE3) harboring the pT7-PCNA plasmid (a generous gift
from B. Stillman, Cold Spring Harbor Laboratory) as described previously (5).
The ﬁnal phenyl Sepharose fractions were loaded on a fast-performance liquid
chromatography Mono Q HR5/5 column equilibrated with buffer A (25 mM
Tris-HCl [pH 7.5], 1 mM EDTA, 10% glycerol, 0.01% Triton X-100, 1 mM
dithiothreitol, 0.1 mM phenylmethylsulfonyl ﬂuoride [PMSF]) containing 0.2 M
NaCl and eluted with 15 ml of 0.2 to 0.7 M NaCl gradient in buffer A. Peak
fractions were stored at 280°C. Human replication protein A (RPA) was also
puriﬁed from recombinant sources by using E. coli BL21(DE3) pLysS trans-
formed with p11d-tRPA (kindly provided by M. Wold, University of Iowa) as
described previously (11). ERCC1-XPF complex was puriﬁed from Chinese
hamster ovary group 1 mutant cells (43-3B) transfected with His-tagged human
ERCC1 as described previously (27). XPA, XPG, TFIIH, and IF7 were puriﬁed
as described previously (1, 7). For TFIIH, the fractions from the second heparin
column were used for the reconstituted NER reactions (14).
Preparation and fractionation of whole-cell extracts. Lymphoblastoid cells
(GM2248B) from an XP-C patient (XP3BE) were grown in suspension with
RPMI 1640 medium containing 15% fetal calf serum and 20 mM HEPES-NaOH
(pH 7.3). Whole-cell extracts were prepared as described previously (18, 36). For
fractionation, whole-cell extracts (;50 mg of protein) were loaded onto a phos-
phocellulose column (1.2 [inside diameter] by 8 cm) equilibrated with buffer B
(25 mM HEPES-KOH [pH 7.8], 1 mM EDTA, 10% glycerol, 0.01% Nonidet
P-40, 1 mM dithiothreitol, 0.1 mM PMSF) containing 0.1 M KCl. After an
extensive wash with the same buffer, bound proteins were eluted with buffer B
containing 1 M KCl. The peak fractions were pooled and dialyzed overnight
against buffer containing 25 mM HEPES-KOH (pH 7.9), 0.1 M KCl, 12 mM
MgCl2, 1 mM EDTA, 10% glycerol, 20% sucrose, and 1 mM dithiothreitol.
Insoluble material was removed by centrifugation, and the resulting supernatant
fraction (column fraction II [CFII]) was stored at 280°C.
In vitro NER reactions. Standard reaction mixtures for in vitro NER (50 ml)
contained the following components: 40 mM HEPES-KOH (pH 7.8), 7 mM
MgCl2, 70 mM KCl, 6.8% glycerol, 0.5 mM dithiothreitol, 2 mM ATP, 20 mM
(each) dGTP, dCTP, and dTTP, 8 mM dATP, 23 mM phosphocreatine, 2.5 mgo f
creatine phosphokinase, 18 mg of bovine serum albumin, 250 ng of each plasmid
DNA substrate, pBluescript II KS1 (AAF [N-acetyl-2-aminoﬂuorene]- or UV-
damaged), and pHM14 (undamaged), and various amounts of fractionated cell
extracts and/or puriﬁed NER proteins. After incubation performed at 30°C for
various periods, 25 ng of PCNA and 74 kBq of [a-
32P]dATP (Amersham) (;110
TBq/mmol) were added and the mixture was further incubated at 30°C for 15
min. For reconstituted NER reactions with puriﬁed proteins, exonuclease-free
E. coli DNA polymerase I (0.025 U; United States Biochemical) was used to
carry out gap ﬁlling of DNA incised by the mammalian incision proteins.
Glycerol gradient velocity sedimentation. Stepwise glycerol gradients were
made in polyallomer ultracentrifuge tubes (for the SW60 rotor; Beckman) by
overlaying 340 ml each of 11-step glycerol solution (from 35 to 15%; 2% decrease
in each step) in buffer C (25 mM Tris-HCl [pH 7.5], 1 mM EDTA, 0.3 M NaCl,
0.05% Nonidet P-40, 1 mM dithiothreitol, 0.1 mM PMSF). The gradients were
incubated overnight at 4°C before loading the samples. Protein samples were put
in 50 ml of buffer C containing 10% glycerol and incubated at 4°C for 2 h. After
the samples were loaded, the gradients were centrifuged at 2°C for 64 h at 49,000
rpm (Beckman SW60 rotor). Fractions (160 ml) were taken from the tops of the
gradients. As marker proteins, egg white lysozyme (2.1S; 30 mg), bovine serum
albumin (4.4S; 27 mg), and yeast alcohol dehydrogenase (7.4S; 40 mg) were
loaded on parallel gradients and fractionated exactly as described above. The
positions of the marker proteins were determined by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) followed by Coomassie bril-
liant blue staining.
Other methods. The rhXPC-binding assay was carried out as described pre-
viously (19). SDS-PAGE was performed as described by Laemmli (15). For
immunoblotting, proteins separated on SDS gels were electrotransferred onto
nitrocellulose membrane (BA85; Schleicher & Schuell) at 5 V/cm overnight in
blot buffer (25 mM Tris, 193 mM glycine, 0.01% SDS, 15% methanol). XPC,
hHR23A, and hHR23B proteins were detected with afﬁnity-puriﬁed rabbit poly-
clonal antibodies raised against each protein and alkaline phosphatase-conju-
gated anti-rabbit immunoglobulin G. The protein concentration was determined
according to the method of Bradford (4), using Coomassie protein assay reagent
(Pierce) and bovine serum albumin as a standard.
RESULTS
Both hHR23 proteins stimulate the activity of XPC protein
in fractionated XP-C cell extracts. To detect XPC-stimulating
activity of recombinant hHR23B protein, we have previously
reported a reconstituted in vitro NER system from which en-
dogenous XPC as well as hHR23B was depleted (28). This
assay system is based on the fact that, when the XP-C whole-
cell extract is fractionated on phosphocellulose as shown in
Fig. 1A, the bound fraction (CFII) is devoid of both XPC and
hHR23B (Fig. 1B). Although XP-C cells still express hHR23B
protein as a free form, all of the hHR23B is recovered in the
ﬂowthrough fraction (CFI). Immunoblotting analysis revealed
that hHR23A is also recovered in CFI and cannot be detected
in CFII upon the same fractionation, regardless of the pres-
ence or absence of XPC expression (Fig. 1B). Because two
puriﬁed NER proteins, RPA and PCNA, are sufﬁcient to func-
FIG. 1. Depletion of endogenous XPC and hHR23 proteins from human whole-cell extracts. (A) Scheme of phosphocellulose fractionation of human whole-cell
extracts. (B) Whole-cell extracts from NER-proﬁcient HeLa cells and XP-C cells [XP3BE(C)] were fractionated on phosphocellulose as illustrated in panel A. The
presence of endogenous XPC, hHR23B, and hHR23A proteins in each fraction was determined by immunoblotting with polyclonal antibodies raised against each
protein. Forty micrograms of whole-cell extract protein (WCE) and 20 mg of CFI and CFII were loaded onto each lane.
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NER system (26), both endogenous hHR23 proteins present in
the XP-C cell extracts can be depleted by this substitution.
Thus, reconstitution of NER reactions with the XP-C CFII,
puriﬁed RPA, and PCNA enabled us to test whether the puri-
ﬁed recombinant hHR23A could functionally replace hHR23B
in this reconstituted system. A two-stage reaction protocol was
used for this experiment. A mixture of AAF-damaged and un-
damaged DNA substrates was incubated with CFII from XP-C
cells and puriﬁed RPA in the presence or absence of rhXPC,
rhHR23B, and rhHR23A. During this ﬁrst incubation, oligo-
nucleotides containing AAF adducts can be excised from plas-
mid DNA substrates when all incision proteins are present. In
the second stage, PCNA and radioactive dATP were added to
allow DNA repair synthesis by DNA polymerases and to label
repair patches. As shown in Fig. 2, rhXPC alone supported
DNA repair synthesis up to threefold over the background
DNA synthesis (Fig. 2, lane 3). In the presence of the same
amountofrhXPC,additionofnontaggedrhHR23Bgaveahigh-
ly reproducible stimulation of repair synthesis, to sixfold over
background (Fig. 2, lane 4), although the repair activity was
signiﬁcantly lower than that achieved with the authentic XPC-
hHR23B complex puriﬁed from HeLa cells (Fig. 2, lane 9). As
expected, the repair reaction was dependent on the presence of
RPA (Fig. 2, lanes 5 and 10). Interestingly, rhHR23A could
also stimulate the rhXPC activity to an extent similar to that
stimulated by rhHR23B (Fig. 2, lanes 7 and 8). No further
stimulation was observed when both hHR23 proteins were
added in one reaction with rhXPC (Fig. 2, lane 6). These data
suggest that hHR23A can functionally substitute for hHR23B
in XPC stimulation in vitro.
hHR23 proteins stimulate XPC protein via complex forma-
tion. To assess complex assembly between rhXPC and rhHR23A,
a His-tagged version of recombinant rhHR23 proteins (rhHR23-
His) was used to coprecipitate rhXPC with nickel-chelating
Sepharose. As shown in Fig. 3, rhXPC itself did not bind to the
nickel beads (Fig. 3, lanes 1 and 2). In the presence of appro-
priate amounts of either rhHR23B-His or rhHR23A-His, how-
ever, rhXPC was coprecipitated almost completely (Fig. 3,
lanes 4 and 6), indicating that rhHR23A is also able to form a
physical complex with rhXPC. To compare the afﬁnity of the
two rhHR23 proteins for rhXPC, nontagged rhHR23 proteins
were included as competitors in the binding reactions. When
equimolar amounts of nontagged and His-tagged rhHR23B
were incubated with rhXPC, about 50% of rhXPC was com-
peted out from rhHR23B-His (Fig. 3, lanes 7 and 8). rhHR23A
could compete for rhXPC binding with rhHR23B-His to a
similar extent (Fig. 3, lanes 9 and 10), indicating that both
rhHR23 proteins have comparable afﬁnity for rhXPC. Since
nontagged rhHR23A was hardly coprecipitated with the
rhXPC-rhHR23B-His complex (Fig. 3, lane 10), formation of a
ternary complex involving rhXPC, rhHR23B, and rhHR23A is
unlikely. Instead, the two rhHR23 proteins bind to rhXPC in a
competitive manner and, most likely, in a 1:1 ratio. Essentially
the same results were obtained with rhHR23A-His (Fig. 3,
lanes 11 to 14), although slightly more rhXPC was competed
out by nontagged proteins when compared with rhHR23B-His.
The reconstitution of rhXPC-rhHR23 complexes was fur-
ther analyzed by sedimentation through glycerol gradients. As
FIG. 2. Stimulation of in vitro NER reactions by rhHR23 proteins. Plasmid
DNA substrates (AAF-damaged [1] and undamaged [2]; 250 ng each) were
incubated at 30°C for 90 min with CFII from XP-C cells (100 mg) and the
indicated puriﬁed proteins under standard conditions for in vitro NER reactions
(see Materials and Methods). After the addition of PCNA (25 ng) and [a-
32P]dATP (74 kBq), incubation was continued at 30°C for 15 min. DNA samples
were puriﬁed, digested with BamHI, and then subjected to agarose gel electro-
phoresis. A photograph of the ethidium bromide-stained gel and an autoradio-
gram of the gel are shown. Incorporation of dAMP into each DNA band was
calculated and depicted as a graph. The average values and standard errors were
calculated from two independent experiments. Symbols: solid bars, incorporation
in damaged plasmid; open bars, incorporation in undamaged control plasmid.
FIG. 3. Both rhHR23 proteins bind to rhXPC. rhXPC (0.25 pmol) was in-
cubated on ice for 1 h with various combinations of 2.5 pmol each of His-tagged
or nontagged rhHR23 proteins as indicated above the lanes. Nickel-chelating
Sepharose was added, and His-tagged proteins were pulled down by centrifuga-
tion after an additional 1-h incubation. Unbound (U) and bound (B) materials
were subjected to SDS-PAGE (9% polyacrylamide gels). The presence of XPC
(upper gel), hHR23B (middle gel), and hHR23A (lower gel) in each fraction was
assessed by immunoblotting. For the detection of hHR23A and hHR23B, anti-
bodies raised against synthetic polypeptides corresponding to a unique sequence
in each protein were used (19).
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4B) sedimented with peaks around 5.6 and 2.5S, respectively.
When rhXPC was prebound to rhHR23B, the position of the
rhXPC peak was slightly shifted toward the bottom of the
gradient, up to around 6.3S (Fig. 4C). This is largely consistent
with the S value determined for XPC-hHR23B complex puri-
ﬁed from HeLa cells (6.2 [20] and 6.1S [25]). In the same gra-
dient, rhHR23B was divided into two peaks, one coinciding with
free rhHR23B and the other with rhXPC, indicating the for-
mation of a physical complex between rhXPC and rhHR23B.
Similar results were obtained with rhXPC and rhHR23A, as
expected (Fig. 4D and E). When the three recombinant pro-
teins were preincubated, both rhHR23 proteins were found in
complex forms (Fig. 4F), in agreement with the results of the
coprecipitation experiments shown in Fig. 3.
To assess whether the complex is responsible for the XPC
stimulation, the peak fractions of free rhXPC and rhXPC-
rhHR23 complexes were assayed for repair activity. As shown
in Fig. 5A, these three peak fractions contained comparable
concentrations of rhXPC. When the same volume of each of
these fractions was assayed, however, both of the complex frac-
tions showed signiﬁcantly higher NER activity than did free
rhXPC (Fig. 5B). Thus, the activity of rhXPC was enhanced by
complex formation with rhHR23 proteins. As shown in Fig. 5C,
1 ml of rhXPC-rhHR23B complex fraction contained 3 to 10 ng
of rhHR23B. On the other hand, when rhHR23B was titrated
in the presence of 1 ml of free rhXPC fraction, approximately
10 times more (30 to 100 ng) rhHR23B was needed to obtain
maximal stimulation (Fig. 5D), likely due to the fact that the
efﬁciency of complex formation is dependent on the concen-
tration of each component. As expected, addition of 100 ng of
rhHR23B did not further stimulate the activity of preformed
rhXPC-rhHR23B complex, although an excess of 1 mgo f
rhHR23B markedly inhibited repair reactions. These data in-
dicated that the presence of rhHR23B is not enough; instead,
complex assembly between XPC and hHR23 proteins is re-
quired for the stimulation of XPC activity.
hHR23 proteins stimulate NER in an early stage of the
reaction. It has previously been shown that the XPC-hHR23B
complex functions at or prior to incisions (25). When the XPC
complex was included only in the second stage (i.e., the DNA
repair synthesis stage), repair could hardly be detected. To
determine which stages of NER are stimulated by hHR23
proteins, two-stage NER reactions were carried out in the
presence of free rhXPC and rhHR23B was added at various
time points. When rhHR23B was present only in the DNA
repair synthesis stage, no stimulation was observed (compare
Fig. 6A, lanes 6 and 7). Furthermore, when rhHR23B was
added at different time points in the ﬁrst stage of the reaction,
the level of DNA repair declined in proportion to incubation
time before the addition of rhHR23B (Fig. 6A, lanes 2 to 5).
Thus, rhHR23B has to be present in the ﬁrst stage of incuba-
tion to exhibit XPC-stimulating activity.
To see whether rhHR23B indeed stimulated NER at or
prior to incision, DNA repair synthesis was uncoupled from
the incision step. After the ﬁrst incubation, DNA substrates
were puriﬁed and the amount of excised DNA damage was
subsequently measured by ﬁlling the repair gaps with T4 DNA
polymerase and radiolabeled deoxynucleoside triphosphates.
As shown in Fig. 6B, authentic XPC-hHR23B complex as well
as reconstituted recombinant protein complex gave speciﬁc
repair signals for damaged DNA (Fig. 6B, lanes 2 and 4) in
an RPA-dependent manner (Fig. 6B, lane 3). Although free
rhXPC gave some repair signal in this assay, coaddition of
rhHR23B displayed clear stimulatory activity (compare Fig.
6B, lanes 5 and 6). These results demonstrate that hHR23B
stimulates some early stages of the NER reaction before DNA
repair synthesis.
hHR23 proteins stimulate NER reconstituted with puriﬁed
proteins. It has previously been reported that damage-depen-
dent incision reactions could be reconstituted in vitro with
seven puriﬁed protein fractions: RPA, XPA, TFIIH, XPC-
hHR23B, ERCC1-XPF, XPG, and incision factor 7 (IF7) (1).
To test whether hHR23 proteins also show stimulatory activity
in this deﬁned NER system, the activity of rhXPC was assessed
in the system with and without rhHR23 proteins. In this ex-
periment, UV-damaged and undamaged DNA substrates were
ﬁrst incubated with puriﬁed incision proteins, and then radio-
active dATP and Klenow fragment were added to allow DNA
repair synthesis. In the presence of appropriate amounts of
other incision proteins, the authentic XPC-hHR23B complex
gave a considerable repair signal (Fig. 7, lane 9). Under the
same conditions, rhXPC hardly supported repair reactions
(Fig. 7, lanes 2 and 3) but the addition of either rhHR23B or
rhHR23A resulted in strong stimulation of repair (Fig. 7, lanes
FIG. 4. In vitro reconstitution of rhXPC-rhHR23 complexes. The indicated
protein samples were fractionated through 15 to 35% glycerol gradients as
described in Materials and Methods. For mixtures of rhXPC and rhHR23, the
samples were preincubated on ice for 2 h before being loaded on the gradients.
Five microliters of each of the indicated fractions were subjected to SDS-PAGE
(6% acrylamide gel), and the presence of each protein was visualized by immu-
noblotting with antibodies raised against each protein. The amounts of proteins
loaded on each gradient were 7.5 mg (rhXPC), 2 mg (rhHR23B), and 1.7 mg
(rhHR23A). Three marker proteins, egg white lysozyme (2.1S), bovine serum
albumin (BSA; 4.4S), and yeast alcohol dehydrogenase (ADH; 7.4S), were cen-
trifuged through parallel gradients, and their peak positions are indicated.
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on the presence of TFIIH (Fig. 7, lanes 5 and 10), conﬁrming
that the signals represented NER reactions. Again, the coad-
dition of rhHR23A and rhHR23B failed to give a higher repair
signal than that achieved by each single rhHR23 protein (Fig.
7, lane 6). Finally, the clear effect of hHR23 proteins in the
deﬁned NER system made up of puriﬁed NER components
provides a strong argument against the theoretical possibility
that the stimulation of hHR23 proteins was in fact due to
titrating out an inhibitory factor(s).
DISCUSSION
Functional interchangeability between the two Rad23 ho-
mologs. In the accompanying paper, a domain in hHR23B
which is responsible for XPC binding was identiﬁed (19). This
domain was shown to be required and even sufﬁcient for stim-
ulation of XPC repair activity in vitro. Because the amino acid
sequence of the domain is well conserved between the two
hHR23 proteins, it might be expected that hHR23A also binds
to XPC and stimulates repair activity. In agreement with this,
E. coli-expressed, highly puriﬁed rhHR23A exhibits an XPC-
stimulating activity similar to that of hHR23B (Fig. 2). Fur-
thermore, coprecipitation with His-tagged rhHR23 proteins
(Fig. 3) and the sedimentation velocity experiments (Fig. 4)
demonstrated that both rhHR23 proteins were capable of
forming complexes with rhXPC. This complex assembly could
be observed without any other protein fractions or any incu-
bation at relatively high temperature, indicating that special
posttranslational modiﬁcations, such as phosphorylation, of
rhHR23 proteins are not necessary for the binding itself.
Moreover, neither an energy source, such as ATP, nor a diva-
lent cation was required.
The competition experiments shown in Fig. 3 revealed that
both rhHR23 proteins can bind to rhXPC with comparable
afﬁnity under the conditions tested. Recently, possible interac-
tion between XPC and hHR23A has been suggested with the
yeast two-hybrid system (16). Furthermore, we have very re-
cently detected trace amounts of hHR23A by immunoblotting
in a highly puriﬁed XPC protein fraction from HeLa cells,
indicating the existence of XPC-hHR23A complex in human
cells (unpublished results). Because the vast majority of XPC is
bound to hHR23B, one might expect that rhHR23B shows
much higher afﬁnity for rhXPC than does rhHR23A. However,
this turned out not to be the case. It is thus still unclear why
most of the XPC is bound to hHR23B. Although the content
of hHR23B in the cells used seems to be higher than that of
hHR23A, the difference is not large enough to explain prefer-
ential binding of XPC to hHR23B (unpublished observations).
It is possible that speciﬁc modiﬁcation of hHR23B increases its
afﬁnity for XPC or, alternatively, that auxiliary factors specif-
ically target XPC to hHR23B. However, this is not absolutely
necessary for the binding itself, as discussed above. Another
possibility is that the subcellular localization of the two hHR23
proteins is different. We have recently shown by indirect im-
FIG. 5. Complex formation with rhHR23 enhances rhXPC activity. (A) The amounts of rhXPC in the glycerol gradient peak fractions of free rhXPC (Fig. 4A,
fraction [Fr.] 15), rhXPC-rhHR23B (Fig. 4C, fraction 17), and rhXPC-rhHR23A (Fig. 4E, fraction 15) were compared by immunoblotting. (B) The three peak fractions
in panel A were assayed for XP-C-correcting activity in the reconstituted in vitro NER system by using XP-C CFII and puriﬁed RPA. After 90 min of incubation at
30°C, PCNA and [a-
32P]dATP were added and the mixture was incubated for another 15 min. Radioactivity incorporated in damaged (closed symbols) and undamaged
(open symbols) plasmids was quantiﬁed and depicted as a graph. Symbols: circle, free rhXPC; triangle, rhXPC-rhHR23B; square, rhXPC-rhHR23A. (C) The amount
of rhHR23B in the peak fraction of rhXPC-rhHR23B was quantiﬁed by immunoblotting. (D) The glycerol gradient peak fractions of free rhXPC and rhXPC-rhHR23B
complex were assayed in the presence of the indicated amounts of rhHR23B under the same conditions as used for panel B. Symbols: solid bar, incorporation in
damaged plasmid; open bar, incorporation in undamaged plasmid. In panels B and D, the mean values and standard errors were calculated from two to four
independent experiments.
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proteins is localized predominantly in the nucleus (30). From
these experiments, however, it was difﬁcult to determine which
fraction of these proteins is present in the cytoplasm. One
possibility is that a minor amount of hHR23B is localized in the
cytoplasm and preferentially traps newly synthesized XPC pro-
tein before it is transported to the nucleus. Alternatively, the
intranuclear localizations of hHR23A and hHR23B may be
different. Further studies are needed to answer these ques-
tions.
Importance of complex assembly for XPC stimulation by
hHR23 proteins. The correlation between XPC-binding and
NER-stimulatory activities of various truncated rhHR23B pro-
teins suggests that complex assembly is important for XPC
stimulation (19). Here we demonstrate biochemically that
complex assembly enhances the repair activity of rhXPC. Be-
cause sedimentation in glycerol gradients incompletely sepa-
rates rhXPC-rhHR23 complexes from free rhXPC, it was dif-
ﬁcult to determine which proportion of rhXPC was complexed
with rhHR23s in each glycerol gradient. However, although
not all rhXPC molecules may have formed complexes, we still
observed a signiﬁcantly higher activity of the complex fractions
than of free rhXPC. Furthermore, when free rhXPC was as-
sayed in the presence of various amounts of rhHR23B, a much
higher concentration of rhHR23B was needed to obtain max-
imal stimulation, in comparison with amounts of rhHR23B
present in the preassembled complex fractions (Fig. 5C and
D). Since the presence of higher concentrations of rhHR23B
should make complex formation more efﬁcient, these data also
support the importance of complex assembly for XPC stimu-
lation by hHR23 proteins. In addition, Fig. 5D shows that the
presence of a large excess of rhHR23B is inhibitory. Conse-
quently, maximal stimulation is observed only within a certain
range of rhHR23B doses. Thus, careful titration of rhHR23B is
necessary for observing the stimulatory effect of rhHR23B.
Because the XPC-hHR23B complex was shown to function
FIG. 6. rhHR23B stimulates early stages of NER. (A) In vitro NER reactions
were carried out with XP-C CFII (100 mg of protein) and RPA (125 ng) in the
presence (1) or absence (2) of rhXPC (30 ng). After ﬁrst-stage reactions at 30°C
for 90 min, PCNA (25 ng) and [a-
32P]dATP (74 kBq) were added and the
mixture was incubated further for 15 min. rhHR23B (43 ng) was added at various
time points as indicated above each lane. An ethidium bromide stain and an
autoradiogram of the agarose gel are shown. (B) In vitro NER reactions were
carried out in the presence of XP-C CFII and the indicated puriﬁed protein
fractions. After incubation at 30°C for 90 min, DNAs were puriﬁed before being
used for DNA synthesis reactions. The DNA synthesis reactions were performed
at 37°C for 15 min in mixtures (50 ml) containing 40 mM HEPES-KOH (pH 7.8),
5 mM MgCl2, 0.5 mM dithiothreitol, 20 mM (each) dGTP, dCTP, and dTTP, 8
mM[ a-
32P]dATP (74 kBq), bovine serum albumin (18 mg), and T4 DNA poly-
merase (0.6 U; New England Biolabs). DNAs were puriﬁed again, digested with
BamHI, and then fractionated by agarose gel electrophoresis.
FIG. 7. rhHR23 proteins stimulate deﬁned NER reactions reconstituted with
puriﬁed proteins. Plasmid DNA substrates (UV damaged and undamaged) were
incubated at 30°C for 60 min in the presence (1) of the indicated puriﬁed NER
proteins. Exonuclease-free E. coli DNA polymerase I and [a-
32P]dATP were
added, and incubation was continued at 30°C for 10 min. DNA samples were
puriﬁed, linearized with BamHI, and separated on a 1% agarose gel. A photo-
graph of the ethidium bromide-stained gel and an autoradiogram of the gel are
shown. The amounts of puriﬁed proteins used were as follows: RPA, 250 ng;
XPA, 45 ng; ERCC1-XPF, 10 ng; TFIIH, 150 ng; XPG, 50 ng; and IF7, 500 ng.
The gel was exposed to a PhosphorImager (Molecular Dynamics), and the
relative radioactivity incorporated in each band was quantiﬁed. Symbols: solid
bars, incorporation in damaged plasmid; open bars, incorporation in undamaged
plasmid.
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which stage of NER is stimulated by hHR23 proteins. By
carrying out DNA repair synthesis independently from inci-
sions, we demonstrated that the stimulation by hHR23 pro-
teins also takes place at or prior to incisions (Fig. 6B). This part
of the NER reaction still encompasses multiple steps: damage
recognition, local melting of double-stranded DNA, dual inci-
sions, and removal of damage-containing oligonucleotides.
Yeast Rad23 protein has previously been claimed (9) to me-
diate physical interactions with Rad14 as well as yeast TFIIH,
raising the possibility that Rad23 promotes assembly of higher-
order NER protein complexes, like “repairosomes” (29). How-
ever, similar interactions have not yet been established either
in vivo or in vitro for hHR23 products and other mammalian
NER proteins. Further studies are warranted to pinpoint the
NER steps in which the hHR23 products exert their func-
tion(s).
Stimulation by rhHR23s in the deﬁned NER system. Our
rhHR23 proteins also showed XPC-stimulating activity in the
deﬁned NER system reconstituted with puriﬁed proteins,
which was described by Aboussekhra et al. (1). Although some
of the repair proteins (i.e., IF7, ERCC1-XPF, and TFIIH)
used in these experiments were not puriﬁed to complete ho-
mogeneity, these observations strongly argue against a formal
possibility that rhHR23s stimulate NER reactions indirectly,
e.g., by titrating out some inhibitors present in crude fractions.
The results of the two reconstituted NER systems with XP-C
CFII (Fig. 2) and the puriﬁed proteins (Fig. 7) were qualita-
tively similar, but we noted some quantitative differences as
well. For instance, free rhXPC always exhibited some activity
when added to the XP-C CFII, whereas the same amount of
rhXPC hardly supported repair in the deﬁned NER system
(compare Fig. 3 and 7, lanes 2 and 3). Consequently, the
stimulation by rhHR23s appeared to be more pronounced in
the deﬁned NER reaction. One possible explanation is that the
XP-C CFII used in these studies still contains a trace amount
of endogenous hHR23B and/or hHR23A. Alternatively, some
repair proteins might be present as higher-order complexes in
the CFII fractions, whereas all repair proteins should be free at
the beginning of the deﬁned NER reactions. If hHR23 pro-
teins promote such supercomplex assembly by themselves or
via change in a conformation of XPC, the deﬁned system
should be much more dependent on the presence of hHR23.
Another possibility is that hHR23 proteins physically stabilize
XPC via complex formation. In the deﬁned NER system, which
contains much lower protein concentrations than the crude
system, free rhXPC might be more labile and thus depend
more on the stabilizing effect of hHR23.
Generally, setting up deﬁned reaction systems composed of
multiple puriﬁed proteins needs special care: rate-limiting fac-
tors depend on the precise ratio of the different puriﬁed pro-
teins used. Therefore, to determine the activity of XPC pro-
tein, it is important to set up reactions where XPC is rate
limiting. Recently Reardon et al. have reported (23) that
rhHR23B had no stimulatory effect in their reconstituted NER
system. There are signiﬁcant differences between the two re-
action systems: one detects repair DNA synthesis on randomly
damaged plasmid DNA, whereas the other detects dual inci-
sion on a singly damaged DNA substrate. Moreover, our de-
ﬁned NER system requires an extra protein fraction, desig-
nated IF7, which seems to be dispensable in the other system.
Therefore, the discrepancy concerning the stimulation by
rhHR23B could be attributed to some intrinsic differences
between the two repair systems, including differences in the
quality of the puriﬁed proteins used. As discussed above, how-
ever, stimulation of XPC might also be overlooked, especially
in deﬁned NER systems, unless all components are carefully
titrated to set up conditions under which XPC is rate limiting.
It is also important to carefully titrate rhHR23B, because a
large excess of rhHR23B turned out to be inhibitory (Fig. 5D).
We are generating knockout mice of mHR23B as well as
mHR23A. Because no natural mutant has so far been available
for mammalian Rad23 homologs, these knockout mice and the
derived mutant cells should give important clues to elucidate in
vivo functions of this set of genes. Analysis of these mice is
expected to give more deﬁnite answers to the current issues
concerning the roles and possible functional redundancy of
mammalian Rad23 homologs in NER, and it will complement
the ﬁndings made in in vitro studies.
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